| Completed | 2 | 10 | Europe | Intravitreal injection ranibizumab, Lucentis | University Hospital, Bonn, Novartis | Choroidal Neovascularization | 04/10 | 04/10 | | |
FVF4140S, NCT00470977: Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy |
|
|
| Completed | 1/2 | 18 | US | ranibizumab injection (0.5 mg), Lucentis | Manhattan Eye, Ear & Throat Hospital, Genentech, Inc. | Coats' Disease, Idiopathic Retinal Telangiectasia, Retinal Angiomatous Proliferation, Polypoidal Choroidal Vasculopathy, Pseudoxanthoma Elasticum, Pathological Myopia, Multi-focal Choroiditis, Rubeosis Iridis, Von Hippel Lindau Disease, BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder) | 12/10 | 12/10 | | |
